Market Closed

ENTA
Enanta Pharmaceuticals
$ 10.99
-1.88%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago

Enanta Pharmaceuticals News

Latest Enanta Pharmaceuticals Stock News & ENTA Headlines

Enanta Pharmaceuticals to Participate in Upcoming Investor Conferences
11 days ago | businesswire.com
Enanta Pharmaceuticals Announces First Patient Dosed in the RESOLVE Phase 2b/3 Study of Zelicapavir, a Potential First-in-Disease Treatment for Respiratory Syncytial Virus (RSV)
20 days ago | businesswire.com
Enanta Pharmaceuticals to Present Data for Zelicapavir, an Oral, Once-Daily, N-Protein Inhibitor, in Development for the Treatment of Respiratory Syncytial Virus, at IDWeek™ 2026
a month ago | businesswire.com
Comparing Enanta Pharmaceuticals (NASDAQ:ENTA) and Amphastar Pharmaceuticals (NASDAQ:AMPH)
a month ago | defenseworld.net
Bank of America Corp DE Reduces Stake in Enanta Pharmaceuticals, Inc. $ENTA
2 months ago | defenseworld.net
Enanta Pharmaceuticals to Participate in September Investor Conferences
2 months ago | gurufocus.com
Enanta Pharmaceuticals to Participate in September Investor Conferences
2 months ago | businesswire.com
Enanta Pharmaceuticals (ENTA) Reports Q3 Loss, Lags Revenue Estimates
3 months ago | zacks.com
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter Ended June 30, 2026
3 months ago | businesswire.com
Enanta Pharmaceuticals (ENTA) Moves 5.2% Higher: Will This Strength Last?
5 months ago | zacks.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

ENTA
Enanta Pharmaceuticals
$ 10.99
-1.88%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago